The influence of glatiramer acetate on Th17-immune response in multiple sclerosis

Glatiramer acetate (GA) is approved for the treatment of multiple sclerosis (MS). However, the mechanism of action of GA in MS is still unclear. In particular, it is not known whether GA can modulate the pro-inflammatory Th17-type immune response in MS. We investigated the effects of original GA (Co...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Melnikov, Mikhail, Sharanova, Svetlana, Sviridova, Anastasiya, Rogovskii, Vladimir, Murugina, Nina, Nikolaeva, Anna, Dagil, Yulia, Murugin, Vladimir, Ospelnikova, Tatiana, Boyko, Alexey, Pashenkov, Mikhail
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599084/
https://ncbi.nlm.nih.gov/pubmed/33126239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0240305
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller